ESG
Bristol Myers Squibb tops Rare Cancers Australia’s Kosi Pharma-Cup
Rare Cancers Australia’s annual Kosi Challenge 2021 climbed to new heights over the weekend raising a staggering $400,000 for Australians living with rare cancers.
Despite the Kosi Challenge presenting one of the toughest walks in its history, with wild winds, thunderstorms and chair lift closures, a record number of 500 participants and teams summited 2,228 meters (above sea level) to the top of Mount Kosciusko to secure this astounding achievement for the rare cancer community.
“We’ve been absolutely blown away with the incredible response this year and witnessing the biggest Kosi Challenge to date,” said Richard Vines, CEO Rare Cancers Australia. “After a very difficult year in 2020 for fundraising activities we were unsure of how this year’s Kosi Challenge would track. I have to say we were not expecting this at all – it’s amazing.”
Now in its 9th year, the Kosi Challenge fund raising efforts were very active in the run-up to this weekend’s event and on the day of the climb – particularly for the hotly contested Kosi and Pharma Cups, both sponsored by Medicines Australia.
The winners of the Pharma Cup – Bristol Myers Squibb raised $81,215 – the largest amount ever achieved by a pharmaceutical company in the history of the Cup. They were followed by Astra Zeneca who raised $51,405 and Janssen with $46,628.
The Kosi Cup for families/friends of loved ones was won by the Prospection Team raising $17,606. The largest, individual fund raiser was Catherine Sertori from Astra Zeneca who raised $19,130.
“It has been such a wonderful weekend. The funds raised will give Rare Cancers Australia substantial momentum to support our community managing rare cancers,” said Richard Vines. “We have to say a massive thank you to all the participants and teams – we could not have achieved this record result with you.
“In particular I want to thank and acknowledge all the patients and carers who took the challenge and conquered the summit. Their stories and bravery inspires us every day and makes sure we stay focused on providing the best care and support we possibly can,” he added.
The Top Teams and Cup Winners
Kosi Pharma-Cup
- Bristol Myers Squibb – $81,215
- Astra Zeneca – $51,405
- Janssen – $46,628
Kosi Cup
- Team Prospection – $17,606
- HT Alpinists – $10,725
- Team Zane – $10,195
Top 3 Individual Fundraisers
- Catherine Sertori – Astra Zeneca $19,130
- Sara Poriters – Roche $9,130
- Helen Pan – BMS $8,700
News & Trends - Pharmaceuticals

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board
Pharma News: Professor John Skerritt has been appointed as an Independent Selected Director on the Medicines Australia Board effective 4 […]
MoreNews & Trends - MedTech & Diagnostics

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech
MedTech & Diagnostics News: In a move aimed at enhancing cystic fibrosis (CF) care and support, Australian-based medical device company, […]
MoreNews & Trends - Pharmaceuticals

Does the evidence support safety concerns following CAR-T cell therapies?
Pharma News: The U.S. Food and Drug Administration (FDA) has launched an investigation into a concerning risk associated with CAR-T […]
More